Helix BioPharma TSX HBP
$0.22 0.0000 0.0000%
Today share price
USA
Sector: Industry:
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

31.05M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

26.81M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-0.09
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

141.13M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

4.76 %
Upcoming events Helix BioPharma All events
No upcoming events scheduled

Stock chart Helix BioPharma

Stock analysis Helix BioPharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-4.22 22.68
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
12.97 5.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-3.12 20.05
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.49 2.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-561.60 17.34

Price change Helix BioPharma per year

0.27$ 1.16$
Min Max

Summary analysis Helix BioPharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Helix BioPharma

Revenue and net income Helix BioPharma

All parameters
Stock news Helix BioPharma All news

About company Helix BioPharma

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.
Address:
Company name: Helix BioPharma
Issuer ticker: HBP
Country: USA
Exchange: TSX
Currency: $
Site:

On which stock exchange are Helix BioPharma (HBP) stocks traded?

Helix BioPharma (HBP) stocks are traded on TSX.

What is the ticker of Helix BioPharma stocks (HBP)?

The stock ticker of Helix BioPharma’s stocks or in other words, the code is HBP. The stocks are currently listed on the TSX exchange.

In which sector and industry does Helix BioPharma (HBP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Helix BioPharma (HBP) belongs to the «» sector and the «» industry.

In what currency are Helix BioPharma (HBP) stocks traded?

Helix BioPharma (HBP) stocks are traded on the TSX exchange in dollars.

What is the price of Helix BioPharma (HBP) stocks today?

The current price of Helix BioPharma stocks on 01.05.2024 is 0.22 dollars. per share.

What is the dynamics of Helix BioPharma (HBP) stocks from the beginning of the year?

Helix BioPharma (HBP) quotes have increased by 29.41% from the beginning of the year up to 0.22 dollars. per 1 stocks.

How much did Helix BioPharma (HBP) stocks increase in мае 2024?

This month Helix BioPharma (HBP) quotes have increased by 0% to 0.22 dollars. per share.

How much are Helix BioPharma (HBP) stocks worth?

Today, on October, 01.05.2024 Helix BioPharma’s (HBP) stocks cost 0.22 dollars..

What is the market capitalization of Helix BioPharma (HBP)?

Capitalization is the market value of Helix BioPharma (HBP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 01.05.2024, the market capitalization of Helix BioPharma (HBP) is estimated at about 31049264 dollars.